Standard BioTools Inc. (LAB) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 488.48M |
| Enterprise Value | 401.09M |
| P/E Ratio | -3.16 |
| PEG Ratio | -0.41 |
| Price/Sales Ratio | 3.58 |
| Price/Book Ratio | 0.55 |
| Enterprise/Revenue | 0.85 |
| Enterprise/EBITDA | -0.89 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -1.09 |
| Operating Margin | -0.91 |
AD
Management Effectiveness
| Return On Assets | -0.15 |
| Return On Equity | -0.21 |
Income Statement
| Revenue | 85.33M |
| Revenue/Share | 0.22 |
| Gross Profit | 42.54M |
| EBITDA | -89.69M |
| Net Income | -74.9M |
| Diluted EPS | -0.2 |
Balance Sheet
| Total Cash | 455.18M |
| Total Cash/Share | 1.17 |
| Total Debt | 29.49M |
| Total Debt/Equity | 0.05 |
| Current Ratio | 12.36 |
| Book Value Per Share | 1.45 |
Price History
| 52-Week Change | -35.6 |
| 52-Week High | 1.72 |
| 52-Week Low | 0.76 |
| Moving Average 50 Days | 0.97 |
| Moving Average 200 Days | 1.2 |
Statistics
| Average Volume | 2.93M |
| Shares Outstanding | 390.37M |
| % Held by Institutions | 77.89 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
